Gene: TP53 ×
Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs28934571
rs28934571
TP53
A 0.700 CausalMutation CLINVAR

dbSNP: rs587782329
rs587782329
TP53
0.020 GeneticVariation BEFREE Neither specific HPV-16 350G/T variants nor specific p53 genotypes were associated with a higher risk of developing CIN III or cervical cancer. 10644829

2000
dbSNP: rs1042522
rs1042522
TP53
0.100 GeneticVariation BEFREE We failed to confirm earlier reports of increased cervical cancer susceptibility in women who harbor the p53 P72R allele. 12142377

2002
dbSNP: rs1131691014
rs1131691014
TP53
0.100 GeneticVariation BEFREE We failed to confirm earlier reports of increased cervical cancer susceptibility in women who harbor the p53 P72R allele. 12142377

2002
dbSNP: rs878854066
rs878854066
TP53
0.100 GeneticVariation BEFREE We failed to confirm earlier reports of increased cervical cancer susceptibility in women who harbor the p53 P72R allele. 12142377

2002
dbSNP: rs1042522
rs1042522
TP53
0.100 GeneticVariation BEFREE Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. 15036661

2004
dbSNP: rs1131691014
rs1131691014
TP53
0.100 GeneticVariation BEFREE Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. 15036661

2004
dbSNP: rs878854066
rs878854066
TP53
0.100 GeneticVariation BEFREE Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. 15036661

2004
dbSNP: rs587782329
rs587782329
TP53
0.020 GeneticVariation BEFREE The E6 variants T350G and A131G have been associated with increased oncogenic potential in cervical cancer patients depending on host genetic factors. 15006625

2004
dbSNP: rs786202962
rs786202962
TP53
0.010 GeneticVariation BEFREE The E6 variants T350G and A131G have been associated with increased oncogenic potential in cervical cancer patients depending on host genetic factors. 15006625

2004
dbSNP: rs1042522
rs1042522
TP53
0.100 GeneticVariation BEFREE The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells. 18205229

2008
dbSNP: rs1131691014
rs1131691014
TP53
0.100 GeneticVariation BEFREE The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells. 18205229

2008
dbSNP: rs878854066
rs878854066
TP53
0.100 GeneticVariation BEFREE The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells. 18205229

2008
dbSNP: rs1042522
rs1042522
TP53
0.100 GeneticVariation BEFREE Driven by findings that human papillomavirus (HPV)-induced degradation of p53 differs by a TP53 polymorphism at codon 72 (Pro72Arg), past studies of TP53 genetic variants and cervical cancer have focused on this nonsynonymous polymorphism, with mixed results. 19423538

2009
dbSNP: rs1131691014
rs1131691014
TP53
0.100 GeneticVariation BEFREE Driven by findings that human papillomavirus (HPV)-induced degradation of p53 differs by a TP53 polymorphism at codon 72 (Pro72Arg), past studies of TP53 genetic variants and cervical cancer have focused on this nonsynonymous polymorphism, with mixed results. 19423538

2009
dbSNP: rs878854066
rs878854066
TP53
0.100 GeneticVariation BEFREE Driven by findings that human papillomavirus (HPV)-induced degradation of p53 differs by a TP53 polymorphism at codon 72 (Pro72Arg), past studies of TP53 genetic variants and cervical cancer have focused on this nonsynonymous polymorphism, with mixed results. 19423538

2009
dbSNP: rs1042522
rs1042522
TP53
0.100 GeneticVariation BEFREE Women carrying the p53 Arg72Pro or p53 Pro72Pro increased the risk of cervical carcinoma (ORs and 95% CIs being 3.74 (2.65-5.30), 2.23 (1.49-3.34)). 19576684

2010
dbSNP: rs1042522
rs1042522
TP53
0.100 GeneticVariation BEFREE To better understand the role of this polymorphism in cervical cancer etiology, we investigated the association between p53 R72P and cervical cancer risk in Chinese women from southern Han. 20193851

2010
dbSNP: rs1131691014
rs1131691014
TP53
0.100 GeneticVariation BEFREE To better understand the role of this polymorphism in cervical cancer etiology, we investigated the association between p53 R72P and cervical cancer risk in Chinese women from southern Han. 20193851

2010
dbSNP: rs1131691014
rs1131691014
TP53
0.100 GeneticVariation BEFREE Women carrying the p53 Arg72Pro or p53 Pro72Pro increased the risk of cervical carcinoma (ORs and 95% CIs being 3.74 (2.65-5.30), 2.23 (1.49-3.34)). 19576684

2010
dbSNP: rs878854066
rs878854066
TP53
0.100 GeneticVariation BEFREE To better understand the role of this polymorphism in cervical cancer etiology, we investigated the association between p53 R72P and cervical cancer risk in Chinese women from southern Han. 20193851

2010
dbSNP: rs878854066
rs878854066
TP53
0.100 GeneticVariation BEFREE Women carrying the p53 Arg72Pro or p53 Pro72Pro increased the risk of cervical carcinoma (ORs and 95% CIs being 3.74 (2.65-5.30), 2.23 (1.49-3.34)). 19576684

2010
dbSNP: rs1042522
rs1042522
TP53
0.100 GeneticVariation BEFREE These results suggest that a heterozygous TP53 Arg72Pro genotype may contribute to cervical cancer susceptibility. 21665181

2011
dbSNP: rs1131691014
rs1131691014
TP53
0.100 GeneticVariation BEFREE These results suggest that a heterozygous TP53 Arg72Pro genotype may contribute to cervical cancer susceptibility. 21665181

2011
dbSNP: rs878854066
rs878854066
TP53
0.100 GeneticVariation BEFREE These results suggest that a heterozygous TP53 Arg72Pro genotype may contribute to cervical cancer susceptibility. 21665181

2011